These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3084381)

  • 1. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Leppla SH; Broster MG; Quinn CP; Melling J
    Med Microbiol Immunol; 1988; 177(5):293-303. PubMed ID: 3139974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for correlates of protective immunity conferred by anthrax vaccine.
    Reuveny S; White MD; Adar YY; Kafri Y; Altboum Z; Gozes Y; Kobiler D; Shafferman A; Velan B
    Infect Immun; 2001 May; 69(5):2888-93. PubMed ID: 11292703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Pezard C; Weber M; Sirard JC; Berche P; Mock M
    Infect Immun; 1995 Apr; 63(4):1369-72. PubMed ID: 7890396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    Zorigt T; Furuta Y; Simbotwe M; Ochi A; Tsujinouchi M; Shawa M; Shimizu T; Isoda N; Enkhtuya J; Higashi H
    PLoS One; 2021; 16(10):e0258317. PubMed ID: 34634075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
    Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
    PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India.
    Varshney A; Puranik N; Kumar M; Pal V; Padmaja J; Goel AK
    Biologicals; 2019 Jan; 57():55-60. PubMed ID: 30635155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
    Quinn CP; Semenova VA; Elie CM; Romero-Steiner S; Greene C; Li H; Stamey K; Steward-Clark E; Schmidt DS; Mothershed E; Pruckler J; Schwartz S; Benson RF; Helsel LO; Holder PF; Johnson SE; Kellum M; Messmer T; Thacker WL; Besser L; Plikaytis BD; Taylor TH; Freeman AE; Wallace KJ; Dull P; Sejvar J; Bruce E; Moreno R; Schuchat A; Lingappa JR; Martin SK; Walls J; Bronsdon M; Carlone GM; Bajani-Ari M; Ashford DA; Stephens DS; Perkins BA
    Emerg Infect Dis; 2002 Oct; 8(10):1103-10. PubMed ID: 12396924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.